Journal of drug targeting · 2005 · 13 citations · 18 references
PharmacyBiochemistryCell BiologyDrug DeliveryGene DeliveryIntracellular TransportAnimal Cell CultureCell-penetrating Delivery SystemsCell-penetrating PeptidesMuscular DystrophyProtein DeliveryProtein TraffickingDystrophin DeficiencyMuscle Gene DeliveryMuscular Dystrophy PathophysiologySkeletal Muscle PhysiologyTargeted TransfectionTransductionTransfection ReagentsWestern Blot Analysis
The Fv fragment of an antibody that selectively targets and penetrates skeletal muscle in vivo was produced as a fusion protein with a micro-dystrophin for use as a delivery vehicle to transport micro-dystrophin into muscle cells. Fv-micro-dystrophin was produced as a secreted protein by transient transfection of Fv-micro-dystrophin cDNA in COS-7 cells and as a non-secreted protein by permanent transfection in Pichia pastoris. Isolated Fv-micro-dystrophin was shown to be full-length by Western blot analysis. Fv-micro-dystrophin penetrated multiple cell lines in vitro, and it localized to the plasma membrane of a cell line with membrane beta-dystroglycan. In the absence of membrane beta-dystroglycan, it localized to the cytoplasm. Antibody-mediated transduction of micro-dystrophin into muscle cells is a potential therapy for dystrophin-deficient muscular dystrophies.
18
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Steven R. Schwarze, Alan L. Ho, Adamina Vocero-Akbani et al. · Science · 1999 · 2.4K citations